SCHEMBL24865833

SCHEMBL24865833

C/C1=C/c2ccccc2N(C=O)Cc2ccccc21

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 5/20 0.37
RAB9A P51151 5/20 0.37
PKM P14618 3/20 0.37
KMT2A Q03164 2/20 0.34
SMN1; SMN2 Q16637 5/20 0.34
MAPT P10636 2/20 0.34
NFKB1 P19838 1/20 0.34
NFKB2 Q00653 1/20 0.34
RELA Q04206 1/20 0.34
ALDH1A1 P00352 2/20 0.33
HPGD P15428 1/20 0.33
KCNN4 O15554 2/20 0.33
KCNA3 P22001 2/20 0.33
GPR84 Q9NQS5 1/20 0.33
CASP3 P42574 1/20 0.33
CASP6 P55212 1/20 0.33
SENP8 Q96LD8 1/20 0.33
SENP7 Q9BQF6 1/20 0.33
SENP6 Q9GZR1 1/20 0.33
TDP1 Q9NUW8 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21065691 0.88 NPC1 (0.34) NPC1RAB9APKMKMT2ASMN1; SMN2
SCHEMBL19313202 0.78 SMN1; SMN2 (0.37) NPC1RAB9APKMKMT2ASMN1; SMN2
SCHEMBL27662180 0.77 KMT2A (0.42) NPC1RAB9APKMKMT2ASMN1; SMN2
SCHEMBL26698297 0.77 NPC1 (0.36) NPC1RAB9APKMKMT2ASMN1; SMN2
SCHEMBL21186552 0.77 NPC1 (0.40) NPC1RAB9APKMKMT2ASMN1; SMN2
SCHEMBL19889885 0.77 HSD17B3 (0.53) SMN1; SMN2KDM4EHTTNOTUM
SCHEMBL21308092 0.75 SMN1; SMN2 (0.35) NPC1RAB9APKMKMT2ASMN1; SMN2
SCHEMBL24994576 0.75 HSD17B3 (0.43) NPC1RAB9APKMKMT2ASMN1; SMN2
SCHEMBL19733503 0.74 HSD17B3 (0.39) SMN1; SMN2MAPTALDH1A1HPGDTDP1
SCHEMBL23569668 0.72 NPC1 (0.33) NPC1RAB9APKMKMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023281479-A1 CHECKPOINT INHIBITORS CONJUGATED TO IL-2, AND USES THEREOF BRIGHT PEAK THERAPEUTICS AG (CH) 2023-01-12 WO disclosed